Hyperion Capital Advisors’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-669,234
Closed -$13.1M 59
2022
Q2
$13.1M Buy
669,234
+1,315
+0.2% +$27.5K 6.12% 6
2022
Q1
$14.5M Buy
667,919
+138,371
+26% +$2.94M 5.48% 7
2021
Q4
$12.5M Buy
+529,548
New +$12.7M 2.79% 11

Other funds holding SHC

Hyperion Capital Advisors's SHC Position: Q3 2022 in Review

Hyperion Capital Advisors sold out of Sotera Health (SHC) in Q3 2022, closing a stake of 669,234 shares — an estimated $13.1M sold.

Hyperion Capital Advisors first reported a position in SHC in Q4 2021 and held it in 3 quarters. The position peaked at $14.5M in Q1 2022. 184 funds tracked by Wall St. Rank hold SHC as of Q3 2022.

  • Hyperion Capital Advisors reported no remaining Sotera Health position as of Q3 2022 after selling out during the quarter.
  • Hyperion Capital Advisors sold 669,234 Sotera Health shares in Q3 2022, an estimated $13.1M.
  • Hyperion Capital Advisors first reported a position in Sotera Health in Q4 2021 and held it in 3 quarters.
  • Hyperion Capital Advisors's Sotera Health position peaked at $14.5M in Q1 2022.
  • 184 funds tracked by Wall St. Rank held Sotera Health as of Q3 2022.

Based on Hyperion Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.